RBC cuts Zscaler stock price target on sales leadership changes

Zscaler beat fiscal Q3 expectations with EPS of $1.08 vs. $1.01 consensus and revenue of $850.48 million vs. $835.55 million, but its fiscal 2027 ARR and revenue growth outlook of 16% to 17% came in below expectations. RBC cut its price target to $200 from $205, while Evercore downgraded the stock and Morgan Stanley lowered its target to $145 amid concerns about sales-leadership turnover and SASE competition. The mixed results and cautious forward guide point to near-term pressure despite solid current execution.

Analysis

The market is treating this as a guidance credibility event, not an earnings print. In security software, valuation de-rates hardest when management signals that sales execution risk may persist into the next budget cycle, because renewal durability matters less than new-logo efficiency for sustaining premium ARR multiples. That means the near-term winner is not a direct competitor so much as the broader group of larger, execution-consistent platforms that can absorb budget share from buyers seeking lower implementation risk.

The second-order read-through is to sales-led cybersecurity peers with high bookings sensitivity and aggressive land-and-expand models: any sign of churn in field leadership raises the discount rate on their forward billings. If ZS’s outlook is conservative because of GTM disruption, the next few quarters could show a mismatch between strong gross margin quality and softer operating leverage, which is precisely the setup that keeps multiple compression in place even if revenue growth holds up.

The contrarian angle is that the selloff may already be pricing in the wrong variable. If the issue is mainly execution turnover rather than demand deceleration, then a stabilizing hire cycle or improved partner motion can re-accelerate bookings within 2-3 quarters, while the current setup offers asymmetric upside if the company simply clears a low bar. The market is implicitly assuming the 16-17% growth guide is a ceiling; if AI/security platform consolidation improves wallet share, that may prove to be a trough growth rate rather than a steady-state rate.

Key catalyst risk is over the next 1-2 quarters: channel checks on new-logo conversion and pipeline coverage will matter more than reported ARR. If sales leadership churn persists, expect a longer multiple reset; if replacement hires are credible and billings re-accelerate, the stock can re-rate quickly because sentiment is already cautious and positioning likely light.

Key Decisions for Investors

• Short ZS into any post-earnings strength, targeting a 1-3 month horizon; use a defined-risk structure (e.g., bearish call spread) because the stock can snap back on any evidence of GTM stabilization.
• Pair trade: long CRWD / short ZS over the next 1-2 quarters to express execution-quality dispersion in cyber; CRWD should benefit if buyers rotate toward platform leaders with less sales-organization risk.
• Avoid chasing the whole cybersecurity basket on this headline; prefer selective exposure until channel data confirms whether this is company-specific or a broader demand slowdown.
• For contrarians, buy ZS only after evidence of sales leadership replacement and pipeline stabilization; risk/reward improves materially if the market starts to believe growth re-accelerates into the next fiscal year.
• If you want optionality, structure a 6-9 month ZS call spread only on confirmation of improved new-logo trends; the upside case is multiple re-rating, but timing risk is high.